Burlington Drug Co., Inc v. Pfizer Inc
Burlington Drug Co., Inc v. Pfizer Inc is a federal antitrust lawsuit filed on 04/23/2012 in the District Court, D. New Jersey. The case was terminated on 10/01/2024.
- Court
- District Court, D. New Jersey (D.N.J.)
Official Court Website → - Assigned judge
- Zahid N. Quraishi · 418 cases in index
- Docket number
- 3:12-cv-02389
- Cause
- 15:1 Antitrust Litigation
15 U.S.C. § 1 — Sherman Antitrust Act - Nature of suit
- 410 Anti-Trust
Claims of unlawful restraint of trade, monopolization, or anticompetitive conduct under the Sherman and Clayton Acts. - Jurisdiction
- Federal Question
- Jury demand
- Both
- Date filed
- 04/23/2012
- Date terminated
- 10/01/2024
1,189 Antitrust cases in this court are indexed here.
Parties
- plaintiff · Burlington Drug Co., Inc · 3 cases
- defendant · Pfizer Inc Pharmaceuticals & Biotechnology · 12528 cases
Part of a Larger Litigation Pattern
This is one of 12,529 Antitrust cases in our index naming PFIZER INC — a possible mass-tort or coordinated-litigation cluster.
About Antitrust Lawsuits
Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.
Frequently Asked Questions
What is Burlington Drug Co., Inc v. Pfizer Inc?
Burlington Drug Co., Inc v. Pfizer Inc is a federal antitrust lawsuit filed on 04/23/2012 in the District Court, D. New Jersey. The case was terminated on 10/01/2024. Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.
What type of case is this?
It is classified as “Antitrust” under the federal nature-of-suit system. Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.
What court is the case in?
The case is in the District Court, D. New Jersey, docket number 3:12-cv-02389.
When was the case filed?
Burlington Drug Co., Inc v. Pfizer Inc was filed on 04/23/2012. It was terminated on 10/01/2024.
What law is the case brought under?
The docket lists the cause as 15 U.S.C. § 1 — Sherman Antitrust Act.
Other Cases Involving These Parties
Related Antitrust Cases
Source: public U.S. federal court record (docket 4310666).